Search for: "Zogenix International Ltd."
Results 1 - 1
of 1
Sort by Relevance
|
Sort by Date
19 Jul 2022, 2:59 pm
In the following guest post, the authors revisit the question of whether or not securities class action lawsuits against development-stage biotech companies are likelier to survive a motion to dismiss compared to securities suits against other kinds of companies. [read post]